Question special
Lead Moderator

There are currently varying levels of evidence for currently utilized strategies for dabigatran reversal for immenent risk of death or major bleeding. I was hoping that the authors and experts would be able to discuss the evidence and their experience with treatments like fresh frozen plasma & apcc or aminocaproic acid? What do you imagine the role for these therapies will be if idarucizumab is approved?